Xceleron (Chapter 11)
Accelerator mass spectrometry to deliver ultra-sensitive analytical solutions for drug development.
Launch date
Market cap
-
Enterprise valuation
€9—13m (Dealroom.co estimates Feb 2012.)
Germantown Maryland (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
£2.0m | Early VC | ||
£2.0m | Series B | ||
N/A | Early VC | ||
| N/A | $100k | Grant | |
$2.4m | Early VC | ||
N/A | Acquisition | ||
| Total Funding | €7.1m | ||
Recent News about Xceleron (Chapter 11)
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.